[Skip to Navigation]
June 2012

Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis: Personalized Medicine in Transition

Author Affiliations

Author Affiliations: Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong, China (Dr Cheung); Singapore Eye Research Institute, Singapore National Eye Centre, Singapore (Drs Cheung and Wong); and Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Australia (Drs Cheung and Wong).

Arch Ophthalmol. 2012;130(6):783-784. doi:10.1001/archophthalmol.2012.727

Despite significant advances in therapeutic strategies, diabetic retinopathy remains a leading cause of preventable vision loss among working-aged people in many developed countries.1 In the United States, about 1 in 4 diabetic patients has signs of retinopathy and 1 in 20 has vision-threatening retinopathy.2 Because early treatment is associated with better outcomes, clinicians routinely try to estimate a patient's risk of visual morbidity from diabetic retinopathy based on traditional risk factors (eg, diabetes duration, glycemic control, and blood pressure control) and retinopathy severity.

Add or change institution